The Metabolic Revolution: Training Dermatologists to be Prepared for/Incorporate/Utilize GLP-1 Agonists and Other Antidiabetics in Skin Disease

Conclusions

• Dermatologists are critical in identifying metabolic conditions through skin manifestations, as patients often present with visible symptoms rather than seeking primary care for underlying issues.
• The low access to primary care highlights the need for dermatologists to expand their role in patient care and screening.
• Metabolic diseases often exhibit warning signs on the skin that are not captured in standard tests performed in primary care.
• Obesity is recognized as a complex disease influenced by multiple hormones, and dermatologists should avoid stigmatizing patients seeking help.
• Many young patients with skin issues are unaware of the connection between their symptoms and metabolic disorders, necessitating education from healthcare professionals.
• Insulin resistance and obesity create a feedback loop that aggravates other health issues, underscoring the need for a holistic treatment approach.
• Dermatologists should actively order metabolic labs for patients showing significant skin findings indicative of metabolic disease, regardless of their weight.
• Prescribing medications such as metformin and GLP-1 agonists can be beneficial for patients with skin disorders linked to metabolic issues, improving both dermatological and overall health outcomes.
• Empowering dermatologists to prescribe lifestyle changes alongside medication can enhance patient motivation and compliance.
• Early intervention in metabolic conditions through dermatological care can significantly improve patient health and potentially reverse severe outcomes.